EU-SAFETY_HEALTH_WORK-PREAMBLE

Safety and Health of Workers at Work Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)

This list contains a non-exhaustive inventory of substances that fall within the scope of the European Union's definition of hazardous chemical and biological substances, as provided on: (1) Table 3 of Annex VI to the CLP Regulation 1272/2008/EC; and (2) Annex III of Directive 2000/54/EC (Biological Agents). The EU's Occupational Safety and Health (OSH) Framework Directive 89/391/EEC applies to risks arising from chemical, physical and biological agents at the workplace.

Last updated 26 April 2024. Database contains 4691 unique substances/entries.

Filter the list

Showing 1 - 200 of 4,691 results.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)
proteases with the exception of those specified elsewhere in this Annex show/hide Proteinase, Bacillus polymyxa neutral EC / List no: 255-914-4 \| CAS no: 42613-33-2 Proteinase, Aspergillus niger neutral EC / List no: 254-422-7 \| CAS no: 39346-39-9 Proteinase, microbial neutral EC / List no: 232-966-6 \| CAS no: 9068-59-1 Proteinase, oryzin EC / List no: 232-992-8 \| CAS no: 9081-30-5 Proteinase, serine EC / List no: 253-431-3 \| CAS no: 37259-58-8 Proteinase, Bacillus subtilis serine EC / List no: 266-557-9 \| CAS no: 67051-83-6 Proteinase, Bacillus alcalophilus serine EC / List no: 306-090-0 \| CAS no: 95979-76-3 Proteinase, rhizopus acid EC / List no: 812-486-9 \| CAS no: 9074-09-3 Proteinase, Aspergillus oryzae neutral EC / List no: 232-990-7 \| CAS no: 9080-55-1 Proteinase, Endothia aspartic EC / List no: 253-395-9 \| CAS no: 37205-60-0 Proteinase, microbial alkaline EC / List no: 256-863-0 \| CAS no: 50936-53-3 Proteinase, microbial acid EC / List no: 256-862-5 \| CAS no: 50936-52-2 Proteinase, Mucor aspartic EC / List no: 232-975-5 \| CAS no: 9073-79-4 Proteinase, Bacillus licheniformis serine EC / List no: 279-361-3 \| CAS no: 79986-26-8 Proteinase, Aspergillus parasiticus neutral EC / List no: 254-418-5 \| CAS no: 39335-09-6 Proteinase, Streptomyces griseus EC / List no: 232-909-5 \| CAS no: 9036-06-0 Amylase, mixed with proteinase, Bacillus cereus-fermented EC / List no: - \| CAS no: 68909-35-3 Proteinase, Aspergillus alkaline EC / List no: 232-977-6 \| CAS no: 9074-07-1 Proteinase, serine (Tritirachium album) EC / List no: 686-165-5 \| CAS no: 102925-54-2 Proteinase, Tritirachium album serine EC / List no: 254-457-8 \| CAS no: 39450-01-6 Proteinase, Aspergillus melleus, semialkaline EC / List no: - \| CAS no: 76106-83-7 Aspergillin M EC / List no: - \| CAS no: 42615-60-1 Proteinase, Bacillus subtilis, sutilain EC / List no: 235-390-3 \| CAS no: 12211-28-8 Proteinase, Serratia extracellular EC / List no: 253-457-5 \| CAS no: 37312-62-2 Proteinase, bacterial E 30 serine EC / List no: - \| CAS no: 39369-34-1 Proteinase, Bacillus subtilis EC / List no: 257-520-8 \| CAS no: 51931-23-8 Amylase, mixture with proteinase EC / List no: 685-079-5 \| CAS no: 9001-11-0 Proteinase, Bacillus subtilis metallo- EC / List no: 232-991-2 \| CAS no: 9080-56-2 Proteinase, Bothrops atrox serine EC / List no: 232-918-4 \| CAS no: 9039-61-6 Proteinase, Aspergillus neutral EC / List no: 278-588-5 \| CAS no: 77000-13-6 Proteinase, Myxobacter α-lytic EC / List no: 253-448-6 \| CAS no: 37288-76-9 Proteinase, Bacillus neutral EC / List no: 278-547-1 \| CAS no: 76774-43-1 Bacteria, complex with amylase and proteinase EC / List no: - \| CAS no: 68920-42-3 Proteinase, Myxobacter AL-1, II EC / List no: 276-716-4 \| CAS no: 72561-05-8 Proteinase, pancreatic EC / List no: 232-626-7 \| CAS no: 9001-72-3 Proteinase, aspartic EC / List no: 278-856-1 \| CAS no: 78169-47-8 Proteinase, submandibular gland serine, A EC / List no: 279-893-6 \| CAS no: 82047-85-6 Proteinase, Bacillus alkaline EC / List no: 232-972-9 \| CAS no: 9073-77-2 Amylase, mixed with proteinase, Bacillus thuringiensis-fermented EC / List no: - \| CAS no: 68909-36-4 Thrombin EC / List no: 232-648-7 \| CAS no: 9002-04-4 Proteinase, Aspergillus acid EC / List no: 232-796-2 \| CAS no: 9025-49-4 Myxobacteralphalyticproteinase EC / List no: - \| CAS no: 12585-31-8 Bacillus megaterium protease fermentation product EC / List no: - \| CAS no: 68909-17-1 Proteinase, Staphylococcus aureus serine EC / List no: 259-611-8 \| CAS no: 55354-32-0 Proteinase, Agkistrodon serine EC / List no: 232-933-6 \| CAS no: 9046-56-4	934-013-6	39450-01-6	Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1
(2RS)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol; mefentrifluconazole	822-682-6	1417782-03-6	Skin Sens. 1
N-methoxy-N-[1-methyl-2-(2,4,6-trichlorophenyl)-ethyl]-3-(difluoromethyl)- 1-methylpyrazole-4-carboxamide; pydiflumetofen	817-852-1	1228284-64-7	Carc. 2; Repr. 2
(RS)-4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole; medetomidine	811-718-6	86347-14-0	Acute Tox. 2; STOT SE 3; STOT SE 1; STOT RE 1
N-(5-chloro-2-isopropylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide; isoflucypram	811-438-4	1255734-28-1	Repr. 2; Acute Tox. 4; Skin Sens. 1B
sulfoxaflor (ISO); [methyl(oxo) {1-[6-(trifluoromethyl)-3-pyridyl]ethyl}-λ6-sulfanylidene]cyanamide	807-366-8	946578-00-3	Acute Tox. 4
4-{[(6-chloropyridin-3-yl)methyl](2,2-difluoroethyl)amino}furan-2(5H)-one; flupyradifurone	804-373-8	951659-40-8	Acute Tox. 4; STOT RE 2
metaflumizone (ISO); (E)-2-[2-(4-cyanophenyl)-1-(a,a,a -trifluoro-m-tolyl) ethylidene]-[4-(trifluoro-methoxy)phenyl]carbani-lohydrazide [2]	701-454-9	852403-68-0	Repr. 2; Lact.; STOT RE 2
6-[C12-18-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acid, sodium and tris(2-hydroxyethyl)ammonium salts	701-271-4	-	Repr. 1B; Eye Irrit. 2
(RS)-1-{1-ethyl-4-[4-mesyl-3-(2-methoxyethoxy)-o-toluoyl]pyrazol-5-yloxy} ethyl methyl carbonate; tolpyralate	701-225-3	1101132-67-5	Carc. 2; Repr. 2; STOT RE 2
6-[C12-18-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acid	701-162-1	-	Repr. 1B
6-[(C10-C13)-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acid	701-118-1	2156592-54-8	Repr. 1B; Eye Irrit. 2
phenol, 3-dodecyl-, branched	701-107-1	1801269-77-1	Repr. 1B; Skin Corr. 1C; Eye Dam. 1
phenol, 2-dodecyl-, branched	701-105-0	1801269-80-6	Repr. 1B; Skin Corr. 1C; Eye Dam. 1
2-methyl-1,2-benzothiazol-3(2H)-one; [MBIT]	695-989-4	2527-66-4	Acute Tox. 4; Acute Tox. 3; Skin Corr. 1C; Eye Dam. 1; Skin Sens. 1A
(5-chloro-2-methoxy-4-methyl-3-pyridyl) (4,5,6-trimethoxy-o-tolyl)methanone; pyriofenone	692-456-8	688046-61-9	Carc. 2
benzovindiflupyr (ISO); N-[9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide	691-719-4	1072957-71-1	Acute Tox. 3
N-{2-[[1,1'-bi (cyclopropyl)]-2-yl] phenyl}-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide; sedaxane	688-331-2	874967-67-6	Carc. 2
di-L-para-menthene	686-814-2	34363-01-4	Skin Irrit. 2; Skin Sens. 1
acetamiprid (ISO); (1E)-N-[(6-chloropyridin-3-yl)methyl]-N’-cyano-N-methylethanimidamide; (E)-N1-[(6-chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidine	682-791-8	160430-64-8	Repr. 2; Acute Tox. 3
tetracopper hexahydroxide sulphate hydrate	682-362-5	12527-76-3	Acute Tox. 4
trinexapac-ethyl (ISO); ethyl 4-[cyclopropyl (hydroxy) methylene]-3,5-dioxocyclohexanecarboxylate	680-302-2	95266-40-3	STOT RE 2; Skin Sens. 1B
diphenyl(4-phenylthiophenyl)sulfonium hexafluoroantimonate	680-227-5	71449-78-0	Skin Sens. 1
amisulbrom (ISO); 3-(3-bromo-6-fluoro-2-methylindol-1-ylsulfonyl)-N,N-dimethyl-1H-1,2,4-triazole-1-sulfonamide	672-776-4	348635-87-0	Carc. 2; Eye Irrit. 2
cyflumetofen (ISO); 2-methoxyethyl (RS)-2-(4-tert-butylphenyl)-2-cyano-3-oxo-3-(α,α,α-trifluoro-o-tolyl)propionate	642-974-5	400882-07-7	Carc. 2; Skin Sens. 1A
hydroxyisohexyl 3-cyclohexene carboxaldehyde (INCI); reaction mass of 4-(4-hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde and 3-(4-hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde	641-410-5	130066-44-3	Skin Sens. 1A
phenol, 4-dodecyl-, branched	640-104-9	210555-94-5	Repr. 1B; Skin Corr. 1C; Eye Dam. 1
α-hydroxypoly(methyl-(3-(2,2,6,6-tetramethylpiperidin-4-yloxy)propyl)siloxane)	639-478-6	182635-99-0	Acute Tox. 4; Skin Corr. 1B
pinoxaden (ISO); 8-(2,6-diethyl-4-methylphenyl)-7-oxo-1,2,4,5-tetrahydro-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-9-yl 2,2-dimethylpropanoate	635-361-9	243973-20-8	Repr. 2; Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Sens. 1A
Reaction mass of 3-(difluoromethyl)-1-methyl-N-[(1RS,4SR,9RS)-1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl]pyrazole-4-carboxamide and 3-(difluoromethyl)-1-methyl-N-[(1RS,4SR,9SR)-1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl]pyrazole-4-carboxamide [≥ 78 % syn isomers ≤ 15 % anti isomers relative content]; isopyrazam	632-619-2	881685-58-1	Carc. 2; Repr. 1B; Skin Sens. 1B
methacrifos (ISO); methyl (E)-3-[(dimethoxyphosphinothioyl)oxy]methacrylate	630-448-8	62610-77-9	Acute Tox. 4; Skin Sens. 1
4-nitrosomorpholine	627-564-6	59-89-2	Carc. 1B; Muta. 2; STOT RE 1
3-bromo-2,2-bis(bromomethyl)propan1-ol	622-370-8	1522-92-5	Carc. 1B; Muta. 2
erionite	620-440-2	12510-42-8	Carc. 1A
diclobutrazole (ISO);(R, R)-(±)-β-[(2,4-dichlorop henyl)methyl]-α-(1,1-dimethylethyl)-1H-1,2,4-triazole-1-ethanol; (2RS, 3RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2- (1H—1,2,4-triazol-1yl)pentan-3-ol	620-436-0	75736-33-3	Eye Irrit. 2
propylenethiourea	620-432-9	2122-19-2	Repr. 2; Acute Tox. 4
guazatine (ISO)	620-427-1	108173-90-6	Acute Tox. 2; Acute Tox. 4; STOT SE 3; Skin Irrit. 2; Eye Dam. 1
azafenidin (ISO); 2-(2,4-dichloro-5-prop-2-ynyloxyphenyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyridine-3(2H)-one	620-425-0	68049-83-2	Repr. 1B; STOT RE 2
dinosam (ISO); 2-(1-methylbutyl)-4,6-dinitrophenol	620-422-4	4097-36-3	Acute Tox. 3
2,4,6-trinitroanisole	620-419-8	606-35-9	Expl. 1.1; Acute Tox. 4
8,9-dinorborn-5-ene-2,3-dicarboxylic anhydride	620-411-4	123748-85-6	Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1
kelevan (ISO); ethyl 5-(perchloro-5-hydroxypentacyclo[5,3,0,02,6,03,9,04,8]decan-5-yl)-4-oxopentanoate; ethyl 5-(1,2,3,5,6,7,8,9,10,10-decachloro-4-hydroxypentacyclo(5,2,1,02,6,03,9,05,8)dec-4-yl)-4-oxovalerate	620-410-9	4234-79-1	Acute Tox. 3; Acute Tox. 4
dichloroacetylene	620-404-6	7572-29-4	Unst. Expl.; Carc. 2; STOT RE 2
basic phenylmercury nitrate	620-403-0	8003-05-2	Acute Tox. 3; STOT RE 1; Skin Corr. 1B
lithium nickel dioxide	620-400-4	12031-65-1	Carc. 1A; STOT RE 1; Skin Sens. 1
cobalt nickel oxide	620-395-9	12737-30-3	Carc. 1A; STOT RE 1; Skin Sens. 1
dimethyl 4-(methylthio)phenyl phosphate	620-379-1	3254-63-5	Acute Tox. 1; Acute Tox. 2
demeton	620-378-6	8065-48-3	Acute Tox. 1; Acute Tox. 2
cyanofenphos (ISO); O-4-cyanophenyl O-ethyl phenylphosphonothioate	620-377-0	13067-93-1	Acute Tox. 3; STOT SE 1; Acute Tox. 4; Eye Irrit. 2
S-[2-(ethylsulphinyl)ethyl] O,O-dimethyl phosphorodithioate	620-370-2	2703-37-9	Acute Tox. 2; Acute Tox. 1
triamiphos (ISO); 5-amino-3-phenyl-1,2,4-triazol-1-yl-N, N,N',N'-tetramethylphosphonic diamide	620-368-1	1031-47-6	Acute Tox. 1; Acute Tox. 2
propineb (ISO); polymeric zinc propylenebis(dithiocarbamate)	620-365-5	9016-72-2	Acute Tox. 4; STOT RE 2; Skin Sens. 1
methyl 3,4-dichlorophenylcarbanilate; SWEP.	620-362-9	1918-18-9	Acute Tox. 4
bufencarb (ISO); reaction mass of 3-(1-methylbutyl)phenyl N-methylcarbamate and 3-(1-ethylpropyl)phenyl N-methylcarbamate	620-359-2	8065-36-9	Acute Tox. 3
3-(4-chlorophenyl)-1,1-dimethyluronium trichloroacetate; monuron-TCA	620-358-7	140-41-0	Carc. 2; Eye Irrit. 2; Skin Irrit. 2
3-(difluoromethyl)-1-methyl-N-(3',4',5'-trifluorobiphenyl-2-yl)pyrazole-4-carboxamide; fluxapyroxad	620-041-3	907204-31-3	Lact.
5-fluoro-1,3-dimethyl-N-[2-(4-methylpentan-2-yl)phenyl]-1H-pyrazole-4-carboxamide; 2'-[(RS)-1,3-dimethylbutyl]-5-fluoro-1,3-dimethylpyrazole-4-carboxanilide; penflufen	619-823-7	494793-67-8	Carc. 2
clethodim (ISO); (5RS)-2-{(1EZ)-1-[(2E)-3-chloroallyloxyimino]propyl}-5-[(2RS)-2-(ethylthio)propyl]-3-hydroxycyclohex-2-en-1-one	619-396-7	99129-21-2	Acute Tox. 4; Skin Sens. 1
sulcotrione (ISO); 2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione	619-394-6	99105-77-8	Repr. 2; STOT RE 2; Skin Sens. 1A
fosthiazate (ISO); (RS)-S-sec-butyl-O-ethyl-2-oxo-1,3-thiazolidin-3-ylphosphonothioate	619-377-3	98886-44-3	Acute Tox. 3; Acute Tox. 4; Skin Sens. 1
ethametsulfuron-methyl (ISO); methyl 2-({[4-ethoxy-6-(methylamino)-1,3,5-triazin-2-yl] carbamoyl}sulfamoyl) benzoate	619-290-0	97780-06-8	Eye Irrit. 2
cyproconazole (ISO); (2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl) butan-2-ol	619-020-1	94361-06-5	Repr. 1B; Acute Tox. 3; STOT RE 2
prosulfuron (ISO); 1-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-[2-(3,3,3-trifluoropropyl)phenylsulfonyl]urea	619-000-2	94125-34-5	Acute Tox. 4
cellulose nitrate; nitrocellulose	618-392-2	9004-70-0	Expl. 1.1
tralkoxydim (ISO); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5-mesitylcyclohex-2-en-1-one	618-075-9	87820-88-0	Carc. 2; Acute Tox. 4
S-metolachlor; reaction mass of (S)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (80-100 %)	618-004-1	87392-12-9	Skin Sens. 1
flusilazole (ISO); bis(4-fluorophenyl)(methyl)(1H-1,2,4-triazol-1-ylmethyl)silane	617-717-5	85509-19-9	Carc. 2; Repr. 1B; Acute Tox. 4
diniconazole (ISO);(E)-β-[(2,4-dichlorophenyl)methylene]-α-(1,1-dimethylethyl)-1H—1,2,4-triazol-1- ethanol;(E)-(RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H—1,2,4- triazol-1-yl)pent-1-en-3-ol	617-485-5	76714-88-0	Acute Tox. 4
bifenthrin (ISO); (2-methylbiphenyl-3-yl)methylrel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate	617-373-6	82657-04-3	Carc. 2; Acute Tox. 3; Acute Tox. 2; STOT RE 1; Skin Sens. 1B
benfuracarb (ISO); ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl-β-alaninate	617-356-3	82560-54-1	Repr. 2; Acute Tox. 3; Acute Tox. 4
clomazone (ISO); 2-(2-chlorobenzyl)-4,4-dimethyl-1,2-oxazolidin-3-one	617-258-0	81777-89-1	Acute Tox. 4
glyphosate-trimesium; glyphosate-trimethylsulfonium	617-243-9	81591-81-3	Acute Tox. 4
imazapyr (ISO);2-[4,5-dihydro-4-methyl-4-(1- methylethyl)-5-oxo-1H- imidazol-2-yl]-3-pyridine carboxylate	617-219-8	81334-34-1	Eye Irrit. 2
sabadilla (ISO);veratrine	617-100-0	8051-02-3	Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
mancozeb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt	616-995-5	8018-01-7	Carc. 2; Repr. 1B; STOT RE 2; Skin Sens. 1
bordeaux mixture; reaction products of copper sulphate with calcium dihydroxide	616-932-1	8011-63-0	Acute Tox. 4; Eye Dam. 1
fluazinam (ISO); 3-chloro-N-[3- chloro-2,6-dinitro-4-(trifluor omethyl)phenyl]-5-(trifluoromethyl)pyridin-2-amine	616-712-5	79622-59-6	Repr. 2; Acute Tox. 4; Eye Dam. 1; Skin Sens. 1A
tefluthrin (ISO); 2,3,5,6-tetrafluoro-4-methylbenzyl (1RS,3RS)-3-[(Z)-2-chloro-3,3,3-trifluoroprop-1-enyl]-2,2-dimethylcyclopropanecarboxylate	616-699-6	79538-32-2	Acute Tox. 1; Acute Tox. 2
fluazifop-P-butyl (ISO); butyl (R)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate	616-669-2	79241-46-6	Repr. 2
iron (II) sulfate (1:1) heptahydrate; sulfuric acid, iron(II) salt (1:1), heptahydrate; ferrous sulfate heptahydrate	616-510-7	7782-63-0	Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2
copper sulphate pentahydrate	616-477-9	7758-99-8	Acute Tox. 4; Eye Dam. 1
Asbestos, tremolite	616-473-7	77536-68-6	Carc. 1A; STOT RE 1
Asbestos, anthophyllite	616-472-1	77536-67-5	Carc. 1A; STOT RE 1
Asbestos, actinolite	616-471-6	77536-66-4	Carc. 1A; STOT RE 1
paclobutrazol (ISO); (2RS,3RS)-1-(4-chlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pentan-3-ol	616-379-6	76738-62-0	Repr. 2; Acute Tox. 4; Eye Irrit. 2
(E)-(7R,11R)-3,7,11,15-tetramethylhexadec-2-ene-1-ol	616-221-6	7541-49-3	Skin Irrit. 2
phenol, (tetrapropenyl) derivatives	616-100-8	74499-35-7	Repr. 1B; Skin Corr. 1C; Eye Dam. 1
zinc sulphate (hydrous) (mono-, hexa-and hepta hydrate)	616-096-8	7446-19-7	Acute Tox. 4; Eye Dam. 1
abamectin (combination of avermectin B1a and avermectin B1b) (ISO)	615-339-5	71751-41-2	Repr. 2; Acute Tox. 2; Acute Tox. 1; STOT RE 1
fenoxaprop-P-ethyl (ISO); ethyl (2R)-2-{4-[(6-chloro-1,3-benzoxazol-2-yl)oxy]phenoxy}propanoate	615-273-7	71283-80-2	STOT RE 2; Skin Sens. 1
metalaxyl-M (ISO); mefenoxam; (R)-2-[(2,6-dimethylphenyl)-methoxyacetylamino]propionic acid methyl ester	615-135-6	70630-17-0	Acute Tox. 4; Eye Dam. 1
triflumizole (ISO); (1E)-N-[4-chloro-2-(trifluoromethyl)phenyl]-1-(1H-imidazol-1-yl)-2-propoxyethanimine	614-708-8	68694-11-1	Repr. 1B; Acute Tox. 4; STOT RE 2; Skin Sens. 1
forchlorfenuron (ISO); 1-(2-chloro-4-pyridyl)-3-phenylurea	614-346-0	68157-60-8	Carc. 2
α-cypermethrin (ISO); racemate comprising (R)-α-cyano-3-phenoxybenzyl (1S,3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; (S)-α-cyano-3-phenoxybenzyl(1R, 3R)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate	614-054-3	67375-30-8	Acute Tox. 3; STOT RE 2; STOT SE 3
potassium (oxido-NNO-azoxy)cyclohexane; cyclohexylhydroxydiazene 1-oxide, potassium salt; [K-HDO]	613-953-8	66603-10-9	Flam. Sol. 1; Acute Tox. 3; STOT RE 2; Skin Irrit. 2; Eye Dam. 1
esfenvalerate (ISO); (S)-α-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-3-methylbutyrate	613-911-9	66230-04-4	Acute Tox. 3; STOT SE 1; STOT RE 2; Skin Sens. 1
flumetralin (ISO); N-(2-chloro-6-fluorobenzyl)-N-ethyl-α, α,α-trifluoro-2,6-dinitro-p-toluidine	613-108-3	62924-70-3	Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1
sec-butyl propionate	611-802-0	591-34-4	Flam. Liq. 3
acequinocyl (ISO); 3-dodecyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl acetate	611-595-7	57960-19-7	Skin Sens. 1; STOT SE 1; STOT RE 2
pyroquilon (ISO);1,2,5,6-tetrahydropyrrolo[3,2,1- ij]quinolin-4-one	611-516-6	57369-32-1	Acute Tox. 4
reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]and 2-methyl-2H-isothiazol-3-one [EC no. 220-239-6] (3:1); reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]and 2-methyl-4-isothiazolin-3-one [EC no. 220-239-6] (3:1)	611-341-5	55965-84-9	Acute Tox. 2; Acute Tox. 3; Skin Corr. 1C; Eye Dam. 1; Skin Sens. 1A
ethyl methyl ether	611-089-6	540-67-0	Flam. Gas 1; Press. Gas
troclosene sodium, dihydrate	610-700-3	51580-86-0	Acute Tox. 4; Eye Irrit. 2; STOT SE 3
pyroxsulam (ISO); N-(5,7-dimethoxy[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-2-methoxy-4-(trifluoromethyl)pyridine-3-sulfonamide	610-007-6	422556-08-9	Skin Sens. 1
tembotrione (ISO); 2-{2- chloro-4-(methylsulfonyl)-3- [(2,2,2-trifluoroethoxy)methyl] benzoyl}cyclohexane-1,3-dione	608-879-8	335104-84-2	Repr. 2; STOT RE 2; Skin Sens. 1
polyhexamethylene biguanide hydrochloride; PHMB	608-723-9	32289-58-0	Carc. 2; Acute Tox. 2; Acute Tox. 4; STOT RE 1; Eye Dam. 1; Skin Sens. 1B
bis(N-hydroxy-N-nitrosocyclohexylaminato-O,O')copper; bis(N-cyclohexyl-diazenium-dioxy)-copper; [Cu-HDO]	608-595-4	312600-89-8	Flam. Sol. 1; Acute Tox. 4; STOT RE 2; Eye Dam. 1
methyl N-(isopropoxycarbonyl)-L-valyl-(3RS)-3-(4-chlorophenyl)-β-alaninate; valifenalate	608-192-3	283159-90-0	Carc. 2
polyhexamethylene biguanide hydrochloride; PHMB	608-042-7	27083-27-8	Carc. 2; Acute Tox. 2; Acute Tox. 4; STOT RE 1; Eye Dam. 1; Skin Sens. 1B
XMC; 3,5-xylyl methylcarbamate	607-955-8	2655-14-3	Acute Tox. 4
piperophos (ISO); S-2-methylpiperidinocarbonylmethyl-O, O-dipropyl phosphorodithioate	607-329-4	24151-93-7	Acute Tox. 4
fluopicolide (ISO); 2,6-dichloro-N-[3-chloro-5-(trifluoromethyl)-2-pyridylmethyl]benzamide	607-285-6	239110-15-7	Repr. 2
3-(3-amino-5-(1-methylguanidino)-1-oxopentylamino-6-(4-amino-2-oxo-2,3-dihydro-pyrimidin-1-yl)-2,3-dihydro-(6H)-pyran-2-carboxylic acid; blasticidin-s	606-640-2	2079-00-7	Acute Tox. 2
tert-butyl propionate	606-566-0	20487-40-5	Flam. Liq. 2
spirotetramat (ISO); (5s,8s)-3- (2,5-dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4,5]dec- 3-en-4-yl ethyl carbonate	606-523-6	203313-25-1	Repr. 2; STOT SE 3; Eye Irrit. 2; Skin Sens. 1A
(+/-)-(R,R)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran; 6-fluoro-2-(2-oxiranyl)chromane	606-373-1	197706-50-6	Skin Sens. 1
proquinazid (ISO); 6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one	606-168-7	189278-12-4	Carc. 2
pyridalyl (ISO); 2,6-dichloro-4-(3,3-dichloroallyloxy)phenyl-3-[5-(trifluoromethyl)-2-pyridyloxy]propyl ether	605-845-4	179101-81-6	Skin Sens. 1
bensultap (ISO); 1,3-bis(phenylsulfonylthio)-2-(N,N-dimethylamino)propane	605-769-1	17606-31-4	Acute Tox. 4
silthiofam (ISO); N-allyl-4,5-dimethyl-2-(trimethylsilyl)thiophene-3-carboxamide	605-752-9	175217-20-6	STOT RE 2
pyraclostrobin (ISO); methyl N-{2-[1-(4-chlorophenyl)-1H-pyrazol-3-yloxymethyl]phenyl}(N-methoxy)carbamate	605-747-1	175013-18-0	Acute Tox. 3; Skin Irrit. 2
indoxacarb (ISO); methyl (4aS)-7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate	605-683-4	173584-44-6	Acute Tox. 3; Acute Tox. 4; STOT RE 1; Skin Sens. 1B
foramsulfuron (ISO); 2-{[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]sulfamoyl}-4-formamido-N,N-dimethylbenzamide; 1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-dimethylcarbamoyl-5-formamidophenylsulfonyl)urea	605-666-1	173159-57-4	Carc. 2
dimethenamid-P (ISO); 2-chloro-N-(2,4-dimethyl-3- thienyl)-N-[(2S)-1-methoxypropan-2-yl]acetamide	605-329-9	163515-14-8	Acute Tox. 4; Skin Sens. 1
flonicamid (ISO); N-(cyanomethyl)-4-(trifluoromethyl)pyridine-3-carboxamide	605-127-0	158062-67-0	Acute Tox. 4
zoxamide (ISO); (RS)-3,5-dichloro-N-(3-chloro-1-ethyl-1-methyl-2-oxopropyl)-p-toluamide	605-037-1	156052-68-5	Skin Sens. 1
emamectin benzoate (ISO); (4''R)-4''-deoxy-4''-(methylamino) avermectin B1 benzoate	605-015-1	155569-91-8	Acute Tox. 3; STOT SE 1; STOT RE 1; Eye Dam. 1
tepraloxydim (ISO); (RS)-(EZ)-2-{1-[(2E)-3-chloroallyloxyimino]propyl}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-one	604-715-4	149979-41-9	Carc. 2; Repr. 2
dimoxystrobin (ISO); (2E)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-(methoxyimino)-N-methylacetamide; (E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide	604-712-8	149961-52-4	Carc. 2; Repr. 2; Acute Tox. 4
spirodiclofen (ISO); 3-(2,4-dichlorophenyl)-2-oxo-1-oxaspiro[4.5]dec-3-en-4-yl 2,2-dimethylbutyrate	604-636-5	148477-71-8	Carc. 1B; Repr. 2; STOT RE 2; Skin Sens. 1B
oxasulfuron (ISO); oxetan-3-yl 2-[(4,6-dimethylpyrimidin-2-yl)-carbamoylsulfamoyl]benzoate	604-430-5	144651-06-9	STOT RE 2
reaction mass of (S)-Indoxacarb and (R)-Indoxacarb 75:25; methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [2]	604-398-2	144171-61-9	Acute Tox. 3; Acute Tox. 4; STOT RE 1; Skin Sens. 1B
(2E)-3-phenylprop-2-enal	604-377-8	14371-10-9	Skin Sens. 1A
kresoxim-methyl (ISO); methyl (E)-2-methoxyimino-[2-(o-tolyloxymethyl)phenyl]acetate	604-351-6	143390-89-0	Carc. 2
cinidon ethyl (ISO); ethyl (Z)-2-chloro-3-[2-chloro-5-(cyclohex-1-ene-1,2-dicarboximido)phenyl]acrylate	604-318-6	142891-20-1	Carc. 2; Skin Sens. 1
tritosulfuron (ISO) (containing ≤0,02 % AMTT); 1-[4-methoxy-6-(trifluoromethyl)-1,3,5-triazin-2-yl]-3-[2-(trifluoromethyl)benzenesulfonyl]urea (containing ≤ 0,02 % AMTT)	604-291-0	142469-14-5	Skin Sens. 1
flufenacet (ISO);N-(4-fluorophenyl)-N-isopropyl-2-(5-trifluoromethyl-[1,3,4]thiadiazol-2-yloxy)acetamide	604-290-5	142459-58-3	Acute Tox. 4; STOT RE 2; Skin Sens. 1
trifloxystrobin (ISO); methyl (E)-methoxyimino-{(E)-α-[1-(α,α,α-trifluoro-m-tolyl) ethylideneaminooxy]-o-tolyl}acetate	604-237-6	141517-21-7	Lact.; Skin Sens. 1
isoxaflutole (ISO); 5-cyclopropyl-1,2-oxazol-4-yl α,α,α-trifluoro-2-mesyl-p-tolyl ketone	604-222-4	141112-29-0	Repr. 2
iprovalicarb (ISO); isopropyl [(2S)-3-methyl-1-{[1-(4-methylphenyl)ethyl]amino}-1-oxobutan-2-yl]carbamate	604-209-3	140923-17-7	Carc. 2
metaflumizone (ISO); (EZ)-2-[2-(4-cyanophe-nyl)-1-(a,a,a -trifluoro-m-tolyl)ethylidene]-[4-(tri-fluoromethoxy)phenyl] carbanilohydrazide [E-iso-mer > 90 %, Z-isomer <10 % relative content]	604-167-6	139968-49-3	Repr. 2; Lact.; STOT RE 2
profoxydim (ISO); 2-{(EZ)-1-[(2RS)-2-(4-chlorophenoxy)propoxyimino]butyl}-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one	604-105-8	139001-49-3	Carc. 2; Repr. 2; Skin Sens. 1
picolinafen (ISO); N-(4-fluorophenyl)-6-[3-(trifluoromethyl)phenoxy] pyridine-2-carboxamide; 4′-fluoro-6-[(α,α,α-trifluoro-m-tolyl) oxy]picolinanilide	604-030-0	137641-05-5	STOT RE 2
acetamiprid (ISO); (1E)-N-[(6-chloropyridin-3-yl)methyl]-N'-cyano-N-methylethanimidamide; (E)-N1-[(6-chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidine	603-921-1	135410-20-7	Repr. 2; Acute Tox. 3
perboric acid (H3BO2(O2)), monosodium salt trihydrate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid (H3BO2(O2)), monosodium salt, trihydrate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]	603-902-8	13517-20-9	Repr. 1B; STOT SE 3; Eye Dam. 1
perboric acid (H3BO2(O2)), monosodium salt trihydrate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid (H3BO2(O2)), monosodium salt, trihydrate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]	603-902-8	13517-20-9	Repr. 1B; Acute Tox. 4; STOT SE 3; Eye Dam. 1
fenpyroximate (ISO); tert-butyl 4-[({(E)-[(1,3-dimethyl-5-phenoxy-1H-pyrazol-4-yl)methylene]amino}oxy)methyl]benzoate	603-792-1	134098-61-6	Acute Tox. 3; Acute Tox. 2; Skin Sens. 1B
azoxystrobin (ISO); methyl (E)-2-{2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate	603-524-3	131860-33-8	Acute Tox. 3
famoxadone (ISO); 3-anilino-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidine-2,4-dione	603-520-1	131807-57-3	STOT RE 2
disodium tetraborate decahydrate	603-411-9	1303-96-4	Repr. 1B
silver zinc zeolite (Zeolite, LTA framework type, surface-modified with silver and zinc ions)	603-404-0	130328-20-0	Repr. 2; Skin Irrit. 2; Eye Dam. 1
triflusulfuron-methyl; methyl 2-({[4-(dimethylamino)-6- (2,2,2-trifluoroethoxy)-1,3,5- triazin-2-yl]carbamoyl}sulfamoyl)-3-methylbenzoate	603-146-9	126535-15-7	Carc. 2
ipconazole (ISO); (1RS,2SR,5RS;1RS,2SR,5SR)-2-(4-chlorobenzyl)-5-isopropyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol	603-038-1	125225-28-7	Repr. 1B; Acute Tox. 4; STOT RE 2
metconazole (ISO); (1RS, 5RS;1RS, 5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol	603-031-3	125116-23-6	Repr. 2; Acute Tox. 4
quinoxyfen (ISO);5,7-dichloro-4-(4-fluorophenoxy)quinoline	602-997-3	124495-18-7	Skin Sens. 1
1-hydroxybenzotriazole, monohydrated	602-929-2	123333-53-9	Expl. 1.3
pymetrozine (ISO); (E)-4,5-dihydro-6-methyl-4-(3-pyridylmethyleneamino)-1,2,4-triazin-3(2H)-one	602-927-1	123312-89-0	Carc. 2; Repr. 2
disodium octaborate tetrahydrate	602-894-3	12280-03-4	Repr. 1B
chlorfenapyr (ISO); 4-bromo-2-(4-chlorophenyl)-1-ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile	602-782-4	122453-73-0	Acute Tox. 3; Acute Tox. 4
white phosphorus	601-810-2	12185-10-3	Pyr. Sol. 1; Acute Tox. 2; Skin Corr. 1A
Disodium tetraborate pentahydrate	601-808-1	12179-04-3	Repr. 1B
Asbestos, grunerite	601-801-3	12172-73-5	Carc. 1A; STOT RE 1
cyprodinil (ISO); 4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine	601-785-8	121552-61-2	Skin Sens. 1
trimagnesium;hydroxy(trioxido)silane;hydrate	601-650-3	12001-29-5	Carc. 1A; STOT RE 1
trimagnesium;disodium;dihydroxy(oxo)silane;iron(3+)	601-649-8	12001-28-4	Carc. 1A; STOT RE 1
difenoconazole (ISO); 1-({2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl} methyl)-1H-1,2,4-triazole; 3-chloro-4-[(2RS,4RS;2RS,4SR)-4-methyl-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-2-yl] phenyl 4-chlorophenyl ether	601-613-1	119446-68-3	Carc. 2; Acute Tox. 4; Eye Irrit. 2
tebufenpyrad (ISO); N-(4-tertbutylbenzyl)-4-chloro-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide	601-585-0	119168-77-3	Acute Tox. 3; Acute Tox. 4; STOT RE 2; Skin Sens. 1B
spiroxamine (ISO); 8-tert-butyl-1,4-dioxaspiro[4.5]decan-2-ylmethyl(ethyl)(propyl)amine	601-505-4	118134-30-8	Repr. 2; Acute Tox. 4; STOT RE 2; Skin Irrit. 2; Skin Sens. 1
imazamox (ISO); (RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinic acid	601-305-7	114311-32-9	Repr. 2
thiacloprid (ISO); (Z)-3-(6-chloro-3-pyridylmethyl)-1,3-thiazolidin-2-ylidenecyanamide; {(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide	601-147-9	111988-49-9	Carc. 2; Repr. 1B; Acute Tox. 4; Acute Tox. 3; STOT SE 3
pethoxamide (ISO); 2-chloro-N-(2-ethoxyethyl)-N-(2-methyl-1-phenylprop-1enyl)acetamide	600-765-6	106700-29-2	Acute Tox. 4; Skin Sens. 1
clodinafop-propargyl (ISO)	600-662-6	105512-06-9	Acute Tox. 4; STOT RE 2; Skin Sens. 1
perboric acid (HBO(O2)), sodium salt, tetrahydrate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid (HBO(O2)), sodium salt, tetrahydrate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]	600-611-8	10486-00-7	Repr. 1B; Acute Tox. 4; STOT SE 3; Eye Dam. 1
perboric acid (HBO(O2)), sodium salt, tetrahydrate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid (HBO(O2)), sodium salt, tetrahydrate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]	600-611-8	10486-00-7	Repr. 1B; STOT SE 3; Eye Dam. 1
difethialone (ISO); 3-[3-(4'-bromobiphenyl-4-yl)-1,2,3,4-tetrahydronaphthalen-1-yl]-4-hydroxy-2H-1-benzothiopyran-2-one	600-594-7	104653-34-1	Repr. 1B; Acute Tox. 1; STOT RE 1
mesotrione(ISO); 2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexanedione	600-533-4	104206-82-8	Repr. 2; STOT RE 2
flumioxazin (ISO); N-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl-2H-1,4-benzoxazin-6-yl)cyclohex-1-ene-1,2-dicarboximide	600-425-7	103361-09-7	Repr. 2
perboric acid (HBO(O2)), sodium salt, monohydrate; sodium peroxoborate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid (HBO(O2)), sodium salt, monohydrate; sodium peroxoborate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]	600-419-4	10332-33-9	Ox. Sol. 3; Repr. 1B; Acute Tox. 4; STOT SE 3; Eye Dam. 1
perboric acid (HBO(O2)), sodium salt, monohydrate; sodium peroxoborate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid (HBO(O2)), sodium salt, monohydrate; sodium peroxoborate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]	600-419-4	10332-33-9	Ox. Sol. 3; Repr. 1B; Acute Tox. 3; Acute Tox. 4; STOT SE 3; Eye Dam. 1
tau-fluvalinate (ISO); cyano-(3-phenoxyphenyl)methyl N-[2-chloro-4-(trifluoromethyl)phenyl]-D-valinate	600-363-0	102851-06-9	Acute Tox. 4; Skin Irrit. 2
halosulfuron-methyl (ISO); methyl 3-chloro-5-{[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]sulfamoyl}-1-methyl-1H-pyrazole-4-carboxylate	600-130-3	100784-20-1	Repr. 1B
reaction product: bisphenol-A-(epichlorhydrin); epoxy resin (number average molecular weight ≤ 700)	500-033-5	25068-38-6	Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1
benzyl(diethylamino)diphenylphosphonium 4-[1,1,1,3,3,3-hexafluoro-2-(4-hydroxyphenyl)propan-2-yl]phenolate	479-100-5	577705-90-9	Repr. 1B
N-(2-nitrophenyl)phosphoric triamide	477-690-9	874819-71-3	Repr. 1B; STOT RE 2
reaction mass of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium; 4-amino-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate potassium/sodium	451-440-9	586372-44-3	Eye Dam. 1
1-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts	451-430-4	500717-36-2	Eye Dam. 1; Skin Sens. 1
reaction mass of: pentasodium; 2-[[8-[[4-chloro-6-[[4-(2-sulfonatethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate; 2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate	450-010-8	-	Eye Dam. 1; Skin Sens. 1
2,2-diethoxy-N, N-dimethylacetamide N,N DIMETHYL DIETHOXY-2,2 ACETAMIDE	449-950-1	34640-92-1	Eye Irrit. 2
11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c, f][1,2]thiazepine hydrochloride	448-720-8	363138-44-7	Acute Tox. 4; Eye Dam. 1
dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate; (5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate AMINODARONE OXALATE; SR33580A	448-700-9	500791-70-8	STOT RE 2; Eye Dam. 1; Skin Sens. 1
reaction mass of 1-[2-(2-aminobutoxy)ethoxy]but-2-ylamine and 1-({[2-(2-aminobutoxy)ethoxy]methyl}propoxy)but-2-ylamine	447-920-2	897393-42-9	Repr. 2; Acute Tox. 4; Skin Corr. 1B; Eye Dam. 1
fatty acids, C18-unsatd., dimers, reaction products with 1-piperazineethanamine and tall oil	447-880-6	206565-89-1	Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
(R, S)-2-amino-3,3-dimethylbutane amide	447-860-7	144177-62-8	Repr. 2; STOT RE 2; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1
2-ethyl-N-methyl-N-(3-methylphenyl)butanamide PARADISAMIDE	446-190-2	406488-30-0	Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1
methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate	445-990-9	376588-17-9	Skin Sens. 1
N, N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane	445-890-5	201290-01-9	Acute Tox. 4; Skin Sens. 1
trans-2-isopropyl-5-carboxy-1,3-dioxane DHP OPT	445-770-2	42031-28-7	Eye Dam. 1
(R, S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanol acetate	445-750-3	839705-03-2	Acute Tox. 4; Eye Dam. 1; Skin Sens. 1
3-chloro-4-(3-fluorobenzyloxy)aniline	445-590-4	202197-26-0	Muta. 2; Acute Tox. 4; STOT RE 2
reaction mass of: pentasodium; 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[-2-sulfonato-4-(2-hydroxyethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate	445-280-9	371921-40-3	Eye Dam. 1; Skin Sens. 1

Showing 1 - 200 of 4,691 results.

Export search results to:

EU-SAFETY_HEALTH_WORK-PREAMBLE

EU-SAFETY_HEALTH_WORK-PREAMBLE

Safety and Health of Workers at Work Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Last updated 26 April 2024. Database contains 4691 unique substances/entries.

Footer Nav Items